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Purpose: To address the question of the safety ofMRI for research in normal, healthy children.We examinedMRI,
neurocognitive and biometric data collected in a group of healthy, normally developing children who have
participated in a 10 year longitudinal fMRI study.
Materials andmethods: Thirty-one healthy children ranging in age from 5 to 7 years were enrolled between 2000
and 2002 and were tested yearly as part of a longitudinal study of normal language development. Twenty-eight
of these children have completed multiple neuroimaging, neurocognitive and biometric exams. These children
ranged in age from 5 to 18 years during the course of the study and were exposed to up to 10 annual MRI
scans. Linear regression of the IQ (WISC-III) (Wechsler, 1991), executive function (BRIEF) (Gioia et al., 2002),
and language (OWLS) (Carrow-Woolfolk, 1995)measures was performed against the number of years of exposure
to MRI in the study. Body mass index (BMI) (Ogden et al., 2006) was also examined as a function of years and
compared with normative values.
Results: TheWISC-III Full Scale (FSIQ) in our longitudinal cohort was higher than the average at baseline. Therewas
no signiﬁcant change over time inmean FSIQ p= 0.80, OWLS p= 0.16, or BRIEF p= 0.67. Similarly, over 10 years
therewere no signiﬁcant changes in the Coding subtest ofWISC III and height and bodymass index did not deviate
from norms (50th percentile).
Conclusions: Examination of neurocognitive and biometric data from a decade-long, longitudinal fMRI study of
normal language development in this small, longitudinal sample of healthy children in the age range of 5 to
18 years, who received up to 10 MRI scans, provides scientiﬁc evidence to support the belief that MRI poses
minimal risk for use in research with healthy children.d Epid
. This© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Examining the current literature on magnetic resonance imaging
(MRI) for keywords relating to biological effects ofMRI turns up primar-
ily articles relating to the operational hazards associated with MRI
(Gangarosa et al., 1987) and protecting patients and radiology personnel
from risks associated with ferromagnetic objects becoming projectiles
in close proximity to MRI magnets (Gallauresi and Woods, 2008;
Shellock and Crues, 2004). There is no question that the beneﬁts out-
weigh the risks of MRI for clinical diagnostic purposes. However, for
research in vulnerable populations such as children and minors who
are dependent on parents or guardians for consent to participate inemiology, Department of
is an open access article under tresearch protocols, it is the responsibility of the research community
to insure that the risk is minimal if there is no direct beneﬁt to the par-
ticipant. Most Institutional Review Boards (IRBs) classify MRI as a min-
imal risk procedure and therefore the risk/beneﬁt ratioworks in favor of
approval for many research protocols involving children as human
subjects. According to the NIH-sanctioned Collaborative Institutional
Training Initiative (CITI) program (Braunschweiger and Goodman,
2007),minimal riskmeans “The probability (of occurrence) andmagni-
tude (seriousness) of harm or discomfort (e.g., psychological, social,
legal, economic) associated with the research are not greater than
those ordinarily encountered in daily life (of the average person in the
general population) or during the performance of routine physical or
psychological examinations or tests.” Minimal risk, therefore, is used
to deﬁne a threshold of anticipated harm or discomfort associated
with the research that is low. This classiﬁcation is based on a lack of
evidence to the contrary.he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Number of scan per subject.






























List and administration time of relevant neuroimaging, cognitive and biometric
measurements for the longitudinal cohort.
Years
Measurements 1 2 3 4 5 6 7 8 9 10
Neuroimaging: MRI X X X X X X X X X X
Cognitive:
WISC-III/WPPSI-III (Wechsler, 1991) X X X
Coding X X X X
WASI X
OWLS (Carrow-Woolfolk, 1995) X X X
Listening comprehension X X X
Oral expression X X X
Oral comprehension X X X
BRIEF (Gioia et al., 2000, 2002) — parent X X X X X
BRI X X X X X
GEC X X X X X
MI X X X X X
Weight X X X X X X X X X X
Height X X X X X X X X X X
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been any acute or long-termdeleterious biological effects attributed toMRI
exposure, aside from the obvious physical injuries that occur because of fer-
romagnetic projectiles colliding with people on their path along the ﬂux
lines of the superconducting magnets that power the MRI machines. Still,
there is a dearth of literature describing systematic studies ofMRI biological
effects using scientiﬁc or epidemiological methods to produce evidence
upon which to base a conclusion or even make an estimate of how large
such effects could be. This study aims to provide scientiﬁc evidence to test
the hypothesis thatMRI producesmeasureable adverse effects on cognitive
and physical development in children who are exposed to repeated MRI
scans between the ages of 5 and 18 years. While there is no existing data
to support this hypothesis that we are aware of and we do not expect our
data to allow us to validate this claim,we are forced to test this positive hy-
pothesis because it is not possible to reject the null hypothesis with any
degree of certainty based on one, small scale study such as the one reported
here. Conversely, we expect to be able to reject the hypothesis that adverse
effects will be found in our sample and to use our data to set an upper
bound on the magnitude of such effects if they exist. Further we expect
our result to provide justiﬁcation for the classiﬁcation of research using
MRI as minimal risk.
Much of the research involving the use of MRI in pediatric popula-
tions is aimed at understanding development and disorders of cognitive
functions such as language and attention. Functional MRI of the devel-
oping brain exposes the brain and the entire human body to a static
magnetic ﬁeld, gradient magnetic ﬁeld changes, and radio frequency
(RF) electromagnetic ﬁelds (Haake et al., 1999). FDA guidelines and
manufacturer limits prevent acute biological effects from RF heating
and peripheral and vestibular nerve stimulation (Zaremba, 2003,
2008). While acute effects of MRI below these limits have not been
reported, researchersmust questionwhether MRI exposure of the cere-
bral cortex, brain stem, thalamus, and neuroendocrine glands thatmod-
erate growth and development could possibly produce long-term
effects, even though mechanisms underlying such effects have not
been described (Chou, 2007; Dini and Abbro, 2005; Robertson et al.,
2009; Weiss et al., 1992). Continued vigilance for such effects is incum-
bent upon us as medical researchers. While we aim to improve child
health through scientiﬁc investigations, harm to human research
subjects and particularly to a vulnerable population of children, is not
an acceptable cost for such scientiﬁc advances.
Here we examine the question of the safety of MRI from the point of
viewof its impact on physical and cognitive growth anddevelopment in
healthy children. We address this question using MRI, cognitive, and
biometric data that we have collected in a group of healthy, normally-
developing children who have participated in a longitudinal study of
language development using fMRI for the past 10 years (Szaﬂarski
et al., 2006). Admittedly our data set is limited and the lack of signiﬁcant
MRI related effects on cognitive and biometric measures does not
preclude discovery of biological effects from repeatedMRI in the future.
However, the data permit us to establish an upper limit for how large an
effect could be and still avoid detection using the gross biometric and
cognitive assessments thatwehave obtained in this longitudinal sample
of healthy children. Controlling for relevant growth variables we are
also able to estimate the sample size needed to detect measureable
effects at speciﬁed levels. A veriﬁable positive ﬁndingwould have impli-
cations for research in children and could allow us to estimate the scale
of the potential impact that MRI exposure might have on the selected
biomarkers. Results of this study establish a baseline for MRI bioeffects
and gauge the necessity and scale for prospective studies of MRI
bioeffects in the future.
2. Materials and methods
A longitudinal cohort of 31 healthy children was enrolled between
2000 and 2002 at age 5 (n = 9), 6 (n = 7) or 7 (n = 15) years.
Twenty-eight (13 girls, 15 boys) of these children have completedmultiple years of annual neuroimaging, biometric, neurological exams,
and cognitive testing as listed in Table 1.
Biometric data reported here include height, weight, and BodyMass
Index (BMI) (Ogden et al., 2006). For each visit, MRI scanningwas com-
pleted, if possible, given the child's status (e.g. orthodontic braces, and
medical status). Cognitive, developmental, and biological measures
were recorded according to the schedule in Table 2 for the longitudinal
cohort. IRB approval was obtained for the study and informed consent
was obtained from parents as well as assent of minor participants.
We examined the longitudinal change in the Wechsler Intelligence
Scale for Children, Third Edition (Wechsler, 1991) (WISC-III) adminis-
tered to children prior to the ﬁrst MRI and after the 3rd and 5th scans.
Data from years 1, 3, and 5 for the FSIQ from WISC-III are reported. In
addition, the Coding subtest from the WISC-III was administered to all
participants again in year 10 and is used to model the longitudinal
trend across all scan years (1st, 3rd, 5th and 10th). We computed the
linear regression of the Coding subtest scores for WISC-III, accounting















1 2 3 4 5 6 7 8 9 10
Number of times















1 2 3 4 5
Year of study
A linear fit of FSIQ with 95% CI
Fig. 1. Linear regression of 10-year longitudinal data fromWISC III Coding subtest (left) and 5 yearWISC III Full Scale IQ scores (FSIQ) (right) against the number of annual exposure with
95% CI.
528 S.K. Holland et al. / NeuroImage: Clinical 4 (2014) 526–530the corresponding 95% conﬁdence interval is shown in Fig. 1.We also ﬁt
a linear regression for the FSIQ obtained from WISC-III across the 1st,
3rd and 5th scan times as displayed in Fig. 1 (right).
In years 6–10, executive functioning was assessed annually by
administering the parent form of the Behavior Rating Inventory of
Executive Function (BRIEF) (Gioia et al., 2000). In this analysis we
use the Global Executive Composite (GEC) score from the BRIEF as
an overarching summary T-score with a mean of 50 and standard
deviation of 10. As with the Wechsler scales above, we ﬁt a regres-
sion model that accounts for the repeated measures nature of the
data to examine the relationship between the number of MRI
scans and these scores. We plotted the ﬁtted line with the corre-
sponding 95% conﬁdence interval as shown in Fig. 2 (right). In addi-
tion, we examined the Oral and Written Language Scales (OWLS)
(Carrow-Woolfolk, 1995) administered to children prior to the
ﬁrst MRI and after the third and ﬁfth annual scans. These results
are also shown graphically in Fig. 2 (left).
Finally, we also evaluated collected biometric data for weight,
height, and Body Mass Index (BMI) in this cohort and compared it to
the corresponding norms, using age- and sex-adjusted data from the
National Center for Health Statistics (NCHS) of the Center for Disease
Control and Prevention (CDC). We used the 5th, 50th and 95th percen-
tiles for bodymass index (BMI) to illustrate the corresponding norm for















1 2 3 4 5
Year of study
A linear fit of mean OWLS with 95% CI A
Fig. 2. Average OWLS Composite scores (left) with 95% CI for the longitudinal cohort and BRIEF
cohort.3. Results
Based on the initial ﬁve years of data using onlyWISC-III FSIQ for the
longitudinal cohort, themean and standard deviation at baseline, year 3,
and year 5 was 117.9(13.5), 118.2(11.1), and 115.8(10.8), respectively.
The resulting slope from the linear ﬁt was−0.09 with p= 0.80, a non-
signiﬁcant result as shown in Fig. 1 (right). Similar non-signiﬁcant
trends were observed for OWLS in years 1, 3, and 5 in mean Listening
Comprehension scores (106.2 (18.6), 105.5(13.1), 110.4(15.28.1);
p = 0.33), Oral Expression scores (110.6(10.9), 109.9(1), 116.1(14.2);
p = 0.435), and Oral Comprehension scores (109.0(14.49), 108.2(11.9),
114.6(14.5); p = 0.17) The linear regression plot of the average OWLS
composite data is given in Fig. 2 (left).
The mean and standard deviation of the Coding subtests obtained
from the WISC-III at baseline and at year 10 was 11.4(3.08) and
10.4(3.5), with a p-value of 0.35. The plot and ﬁt of the data across
years 1, 3, 5 and 10 have a non-signiﬁcant slope (p= 0.15) as illustrated
in Fig. 1 (left). The mean BRIEF GEC scores in years 6–10 were
(49.5(9.3), 45.6(7.5), 47.3(11.2), 47.0(10.0) and 46.1(9.3); p = 0.67)
respectively; again the trend in the linear regression with the number
of annual MRI scans does not reach signiﬁcance (Fig. 2, right).
Similarly, the body mass index did not deviate from norms (50th
percentile) and most of the measurements are within the 5th and
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Year of study
 linear fit of BRIEF as measured by GEC and year of scan with 95% CI
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Longitudinal CDC 95th% CDC 5th %
Scatter plot of BMI for the longitudinal cohort along the CDC 5th & 95th percentile
Fig. 3. Scatter plot of body mass index (BMI) against age in years for longitudinal cohort
data (bottom-right).
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cohort at baseline render comparisons with the population norms for
the tests irrelevant. For example, the mean and standard deviation
WISC-III FSIQ at baseline was 117.9 ± 13.5. Comparing our cohort
directly with norms (100 ± 15) might suggest that only higher scoring
children participate in MRI brain imaging research studies, which is not
a relevant point to this study. Consequently we focus primarily on
analysis of the trends in biometric and cognitive scores over time,
relative to normative trends.
4. Discussion
Adverse cognitive or biological effects from repeated MRI scans are
not evident in the data from this longitudinal sample of children in
the age range of 5 to 18 years using the gross cognitive and growth
rate measures administered during the course of 10 years of exposure
to annual MRI scans. The effect size estimated as the least square
mean difference between the scores at the last and ﬁrst time points is
small (effect size for WISC FSIQ = 0.17, BRIEF = 0.31 and OWLS =
0.38) and without consistent positive or negative trends. This suggests
that any changes due to repeated MRI scanning are likely to be very
subtle and not clinically signiﬁcant. Based on these effect sizes, estimat-
ed sample sizes of 280, 83, and 55would be needed to detect signiﬁcant
positive or negative changes over time in FSIQ, BRIEF, and OWLS,
respectively. These estimates are based on ﬁve-year average exposure
of MRI scans and 80% power.
It is not possible to prove conclusively that deleterious effects do
not occur with repeated MRI in children and the present data can
only be properly interpreted as an upper limit on how safe repeated
MRI can be for children in the speciﬁc age range of 5 to 18 years. In
the present study, change over time for cognitive measures was
less than the standard error for these measures. This magnitude of
change is within the range that would be expected for retesting
children on these measures, regardless of whether they had received
repeatedMRI. Likewise, the distribution of BMI is not distinguishable
from normal trends.
We attempted to minimize practice effects on the WISC-III and
WAIS-III by not repeating the tests every year. The tests were adminis-
tered every other year in most cases and the WASI test was adminis-
tered 5 years after the last exposure to WISC for most children. The
“Flynn Effect” is also known to result in increasing IQ scores in popula-
tions, related to increases in ﬂuid and crystallized intelligence over
time (Flynn, 1994). If practice effects or Flynn Effect are present in our
dataset, it would tend to inﬂate the cognitive test scores over time.
Such an effect could be offset in our data by decreasing cognitive ability
due to the repeated MRI exposures. There is no way to disambiguatethese factors based on our retrospective study design and data we
have collected and this is a limitation of the study. Other limitations
of this retrospective study on the potential impact of repeated MRI
exposure on physical and cognitive growth and development in healthy
children include the small sample size, inconsistent cognitive testing
due to the wide age range and a lack of cognitive measures speciﬁcally
designed to be sensitive to longitudinal trends.
While each individual in the group may have a different trend for a
speciﬁc measure collected at different time points, positive or negative
variations in individual trends are expected. Inmost cases the variations
in individual trends, upward or downward with time, fall within the
standard deviations of the measures. To make the association between
MRI exposure and neurobehavioral or biometric measures, we can
only make statistical inferences from the group data. In this case we
are able to estimate the signiﬁcance of the trends relative to norms
from the general population and generalize our ﬁndings to the larger
population. At the group level none of these trends is statistically
signiﬁcant.
Despite the limitations described above, we are able to reject the
ﬁrst part of our initial hypothesis, that repeated exposure to MRI
produces measureable adverse effects on neurocognitive development
in children who are exposed to repeated MRI scan between the ages
of 5 and 18 years. The biometric data in Fig. 3, although limited to BMI
trends, also points to the rejection of the hypothesis that repeated expo-
sure to MRI produces measureable adverse effects on physical develop-
ment, though admittedly BMI is a very gross biometric measure and
does not allow us to explore impact of MRI on speciﬁc areas of growth
and development.
If direct evidence for an adverse interaction ofmagneticﬁelds orMRI
with biological systems is identiﬁed, then researchers using MRI to
study human development must pause to consider the implications.
Until such amechanism is discoveredwe can only examine the relation-
ships betweenMRI exposure and biological and behavioral measures of
development using an epidemiological approach. Recent discussion of
the safety of MRI for research in healthy children (Holland et al., 2010;
Jiao, 2010; Prato et al., 2010)motivates us to use this approach to exam-
ine data from our longitudinal cohort of pediatric subjects as they grow
into adulthood.
Future studies should be conducted comparing participants who
have had repeated MRI scans to a normative control group without
exposure. Ideally, a prospective study from birth to adulthood would
be conducted in a large cohort of participants in a longitudinal study
with repeated exposures to MRI along with consistent cognitive
assessments using instruments designed to be administered repeatedly
without inﬂuence from practice effects. There are a number of such
instruments available such as the ANAM (Kabat et al., 2001) and
Cogstate (Falleti et al., 2006). Generally these tests are designed to
test for subtle decline in cognitive ability due to brain injury or
neurodegenerative diseases in adults. However, there are few such in-
struments with norms for children. By our own estimates for effect
sizes described above, cohorts of 100 to 300 children would be needed
to detect signiﬁcant changes over timeusing the grossmeasureswehad
available for this retrospective study. Using modern computer-based
cognitive assessments designed to avoid practice effects in repeated
administrations of the tests should improve sensitivity and might
reduce sample size requirements. However, this type of study will
take decades to complete and there are many disincentives to perform
it, including cost, perceived risk to subjects, and reluctance in the
medical community and corporate interests to turn up any adverse ef-
fects fromMRI in children. Given the lack of evidence for acute adverse
effects fromMRI scanning during its long history and widespread clini-
cal use, it appears unlikely that such effects exist. The beneﬁt of MRI for
clinical diagnosis is unequivocal and the medical-legal system in the
United States weighs heavily in favor of using MRI in children to avoid
missing a diagnosis or subjecting children to more invasive or risky
procedures such as biopsies or X-rays. Consequently it is unlikely that
530 S.K. Holland et al. / NeuroImage: Clinical 4 (2014) 526–530the ideal prospective, longitudinal MRI bioeffects study will ever be
funded or conducted in children. Meanwhile the data reported here
provide some level of assurance that up to 10MRI scans do not produce
observable deleterious bioeffects in children and the results can be used
to deﬁne a framework for the design of a larger scale study.
5. Conclusion
Examination of cognitive and biometric data from a decade-long
longitudinal fMRI study of normal language development in this small,
longitudinal sample of healthy children in the age range of 5 to
18 years, who received up to 10 MRI scans, provides evidence to sup-
port the belief that MRI poses minimal (if any) risk for use in research
with healthy children.
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